These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7079683)

  • 1. [Hepatitis B virus epidemiology: degree of contamination and hyperreactors].
    Pfenninger-Schaer K; Frey-Wettstein M; Grob PJ
    Schweiz Med Wochenschr; 1982 Apr; 112(14):478-82. PubMed ID: 7079683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serologic markers for hepatitis B virus in a group of healthy individuals (author's transl)].
    Vargas V; Pedreira JD; Esteban R; Hernández JM; Piqueras J; Guardia J
    Med Clin (Barc); 1982 Apr; 78(7):265-7. PubMed ID: 7087592
    [No Abstract]   [Full Text] [Related]  

  • 3. [Maternal-fetal transmission of hepatitis B virus. Follow-up study of 21 infants born to HBSAG-positive mothers, and 6 born to HBSAG-negative mothers with anti-HBV antibodies].
    Manzillo G; Sagnelli E; Da Villa G; Maio G; Izzo CM; Felaco F; Filippini P; Buonocore S; Piccinino F
    Minerva Med; 1980 Oct; 71(42):3067-71. PubMed ID: 7266910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Italian blood donors with anti-HBc and occult hepatitis B virus infection.
    Manzini P; Girotto M; Borsotti R; Giachino O; Guaschino R; Lanteri M; Testa D; Ghiazza P; Vacchini M; Danielle F; Pizzi A; Valpreda C; Castagno F; Curti F; Magistroni P; Abate ML; Smedile A; Rizzetto M
    Haematologica; 2007 Dec; 92(12):1664-70. PubMed ID: 18055990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen.
    Marusawa H; Uemoto S; Hijikata M; Ueda Y; Tanaka K; Shimotohno K; Chiba T
    Hepatology; 2000 Feb; 31(2):488-95. PubMed ID: 10655275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor screening for hepatitis B virus infection in a cell and tissue bank.
    Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ
    Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological profiles of hepatitis B carrier patients in Singapore with special reference to the frequency and significance of concurrent presence of HBsAg and anti-HBs.
    Wang YM; Ng WC; Kang JY; Yap I; Seet BL; Teo J; Smith R; Guan R
    Singapore Med J; 1996 Apr; 37(2):150-2. PubMed ID: 8942251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation].
    Bujanda L; García Bengoechea M; Cilla G; Gil I; yArenas JI
    Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Occurrence of HB-s antigens and antiHB-s antibodies in blood donors at the Gdańsk Blood Transfusion Center].
    Ledóchowki H; Nowakowska E
    Acta Haematol Pol; 1978; 9(2):101-5. PubMed ID: 665129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of the "isolated anti-HBc" serological pattern determinated by the serological response to the vaccination against Hepatitis B].
    Coz Yataco A; Lozano Miranda A; Samalvides Cuba F; Antunez de Mayolo Ramis E
    Rev Gastroenterol Peru; 2005; 25(3):254-8. PubMed ID: 16237469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recommendations concerning anti-HBs in transfusion blood and application of anti-hepatitis B immunoglobulin concentrations in the prevention of hepatitis B].
    van Loghem JJ
    Ned Tijdschr Geneeskd; 1979 Oct; 123(43):1874-5. PubMed ID: 514376
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis B virus infection in allogeneic bone marrow transplantation.
    Ustün C; Koç H; Karayalcin S; Akyol G; Gürman G; Ilhan O; Akan H; Ozcan M; Arslan O; Konuk N; Uysal A; Beksaç M
    Bone Marrow Transplant; 1997 Aug; 20(4):289-96. PubMed ID: 9285543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Occurrence of HBs-antigen and anti-HBs in patients with porphyria cutanea tarda (author's transl)].
    Goerz G; Uthemann H; Lissner R
    Z Gastroenterol; 1979 May; 17(5):296-300. PubMed ID: 463171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Persistence of immunity after hepatitis B vaccination].
    Madaliński K
    Przegl Epidemiol; 2002; 56(4):605-13. PubMed ID: 12666586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated antibodies against the core antigen of hepatitis B virus in HIV-infected patients.
    Neau D; Winnock M; Galpérine T; Jouvencel AC; Castéra L; Legrand E; Tranchant E; Balestre E; Lacoste D; Ragnaud JM; Dupon M; Lafon ME; Dabis F;
    HIV Med; 2004 May; 5(3):171-3. PubMed ID: 15139983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Virus antibodies and the infectiousness of serum in hepatitis B].
    Niermeijer P; Gips CH
    Ned Tijdschr Geneeskd; 1979 Apr; 123(17):716. PubMed ID: 375104
    [No Abstract]   [Full Text] [Related]  

  • 18. [Infection/immunity by hepatitis B virus in an adult population of Havana City. Cuba 1995].
    Rodríguez Lay LA; Díaz González M; Bravo J; Pedroso Flaquet P; Díaz Mendiondo B
    Rev Cubana Med Trop; 1999; 51(3):206-7. PubMed ID: 10887591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determination of hepatitis B E antigens, anti-hepatitis B E and Dane particles in the serum of hepatitis B S carriers and patients with chronic hepatitis B S antigen-positive hepatitis].
    Reichlin B; Stalder GA; Gudat F; Bianchi L; Froesner GG
    Schweiz Med Wochenschr; 1982 Apr; 112(15):523-4. PubMed ID: 7079688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
    Sheng WH; Kao JH; Chen PJ; Huang LM; Chang SY; Sun HY; Hung CC; Chen MY; Chang SC
    Clin Infect Dis; 2007 Nov; 45(9):1221-9. PubMed ID: 17918088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.